Defining a screening tool for post-traumatic stress disorder in East Africa: a penalized regression approach.

East Africa (Kenya) low and middle income countries (LMIC) posttraumatic stress disorder (PTSD) primary care screening tools sub Saharan Africa traumatic stress

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 07 02 2024
accepted: 13 05 2024
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: epublish

Résumé

Scalable PTSD screening strategies must be brief, accurate and capable of administration by a non-specialized workforce. We used PTSD as determined by the structured clinical interview as our gold standard and considered predictors sets of (a) Posttraumatic Stress Checklist-5 (PCL-5), (b) Primary Care PTSD Screen for the DSM-5 (PC-PTSD) and, (c) PCL-5 and PC-PTSD questions to identify the optimal items for PTSD screening for public sector settings in Kenya. A logistic regression model using LASSO was fit by minimizing the average squared error in the validation data. Area under the receiver operating characteristic curve (AUROC) measured discrimination performance. Penalized regression analysis suggested a screening tool that sums the Likert scale values of two PCL-5 questions-intrusive thoughts of the stressful experience (#1) and insomnia (#21). This had an AUROC of 0.85 (using hold-out test data) for predicting PTSD as evaluated by the MINI, which outperformed the PC-PTSD. The AUROC was similar in subgroups defined by age, sex, and number of categories of trauma experienced (all AUROCs>0.83) except those with no trauma history- AUROC was 0.78. In some East African settings, a 2-item PTSD screening tool may outperform longer screeners and is easily scaled by a non-specialist workforce.

Sections du résumé

Background UNASSIGNED
Scalable PTSD screening strategies must be brief, accurate and capable of administration by a non-specialized workforce.
Methods UNASSIGNED
We used PTSD as determined by the structured clinical interview as our gold standard and considered predictors sets of (a) Posttraumatic Stress Checklist-5 (PCL-5), (b) Primary Care PTSD Screen for the DSM-5 (PC-PTSD) and, (c) PCL-5 and PC-PTSD questions to identify the optimal items for PTSD screening for public sector settings in Kenya. A logistic regression model using LASSO was fit by minimizing the average squared error in the validation data. Area under the receiver operating characteristic curve (AUROC) measured discrimination performance.
Results UNASSIGNED
Penalized regression analysis suggested a screening tool that sums the Likert scale values of two PCL-5 questions-intrusive thoughts of the stressful experience (#1) and insomnia (#21). This had an AUROC of 0.85 (using hold-out test data) for predicting PTSD as evaluated by the MINI, which outperformed the PC-PTSD. The AUROC was similar in subgroups defined by age, sex, and number of categories of trauma experienced (all AUROCs>0.83) except those with no trauma history- AUROC was 0.78.
Conclusion UNASSIGNED
In some East African settings, a 2-item PTSD screening tool may outperform longer screeners and is easily scaled by a non-specialist workforce.

Identifiants

pubmed: 38947359
doi: 10.3389/fpubh.2024.1383171
pmc: PMC11211862
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383171

Informations de copyright

Copyright © 2024 Meffert, Mathai, Ongeri, Neylan, Mwai, Onyango, Akena, Rota, Otieno, Obura, Wangia, Opiyo, Muchembre, Oluoch, Wambura, Mbwayo, Kahn, Cohen, Bukusi, Aarons, Burger, Jin, McCulloch and Njuguna Kahonge.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Susan M Meffert (SM)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States.

Muthoni A Mathai (MA)

Department of Psychiatry, University of Nairobi, Nairobi, Kenya.

Linnet Ongeri (L)

Kenya Medical Research Institute, Nairobi, Kenya.

Thomas C Neylan (TC)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States.

Daniel Mwai (D)

Department of Health Economics, University of Nairobi, Nairobi, Kenya.

Dickens Onyango (D)

Kisumu County Ministry of Health, Kisumu, Kenya.

Dickens Akena (D)

Department of Psychiatry, Makerere University, Kampala, Uganda.

Grace Rota (G)

Department of Psychiatry, Makerere University, Kampala, Uganda.

Ammon Otieno (A)

Department of Psychiatry, Makerere University, Kampala, Uganda.

Raymond R Obura (RR)

Global Programs for Research and Training, Nairobi, Kenya.

Josline Wangia (J)

University of Nairobi, Nairobi, Kenya.

Elizabeth Opiyo (E)

University of Nairobi, Nairobi, Kenya.

Peter Muchembre (P)

Global Programs for Research and Training, Nairobi, Kenya.

Dennis Oluoch (D)

Global Programs for Research and Training, Nairobi, Kenya.

Raphael Wambura (R)

Kisumu County Ministry of Health, Kisumu, Kenya.

Anne Mbwayo (A)

Department of Psychiatry, University of Nairobi, Nairobi, Kenya.

James G Kahn (JG)

Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, United States.
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

Craig R Cohen (CR)

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, United States.

David E Bukusi (DE)

Department of Psychiatry, University of Nairobi, Nairobi, Kenya.

Gregory A Aarons (GA)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States.

Rachel L Burger (RL)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States.

Chengshi Jin (C)

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

Charles E McCulloch (CE)

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

Simon Njuguna Kahonge (S)

Kenya Ministry of Health, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH